Eric D. Moher

1.2k total citations
28 papers, 860 citations indexed

About

Eric D. Moher is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eric D. Moher has authored 28 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Eric D. Moher's work include Synthetic Organic Chemistry Methods (8 papers), Microbial Natural Products and Biosynthesis (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). Eric D. Moher is often cited by papers focused on Synthetic Organic Chemistry Methods (8 papers), Microbial Natural Products and Biosynthesis (6 papers) and Asymmetric Synthesis and Catalysis (5 papers). Eric D. Moher collaborates with scholars based in United States, Spain and Canada. Eric D. Moher's co-authors include Michael J. Martinelli, Paul A. Grieco, Naresh K. Nayyar, Ulhas P. Dhokte, Rajappa Vaidyanathan, Joseph M. Pawlak, Jon L. Collins, Thomas J. Fleck, Vien V. Khau and Jian Liang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Inorganic Chemistry.

In The Last Decade

Eric D. Moher

28 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric D. Moher United States 16 616 351 161 130 74 28 860
William R. Bartlett United States 8 594 1.0× 235 0.7× 97 0.6× 113 0.9× 78 1.1× 12 787
Tooru Kuroda Japan 15 621 1.0× 261 0.7× 81 0.5× 66 0.5× 78 1.1× 28 772
Ronald C. Bernotas United States 19 951 1.5× 549 1.6× 130 0.8× 57 0.4× 37 0.5× 43 1.2k
R. Satheesh Babu India 17 948 1.5× 522 1.5× 153 1.0× 74 0.6× 27 0.4× 28 1.2k
Karl R. Gibson United Kingdom 15 460 0.7× 255 0.7× 96 0.6× 164 1.3× 32 0.4× 27 796
Ed Cleator United Kingdom 17 777 1.3× 318 0.9× 78 0.5× 92 0.7× 72 1.0× 39 998
Lilya U. Dzhemileva Russia 17 545 0.9× 389 1.1× 113 0.7× 70 0.5× 89 1.2× 95 920
Qiyan Lin China 13 472 0.8× 231 0.7× 133 0.8× 186 1.4× 25 0.3× 29 735
Takahiko Taniguchi Japan 22 1.1k 1.8× 649 1.8× 181 1.1× 89 0.7× 92 1.2× 78 1.5k
Robert J. Ferrier New Zealand 17 1.3k 2.1× 786 2.2× 150 0.9× 126 1.0× 65 0.9× 70 1.4k

Countries citing papers authored by Eric D. Moher

Since Specialization
Citations

This map shows the geographic impact of Eric D. Moher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Moher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Moher more than expected).

Fields of papers citing papers by Eric D. Moher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Moher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Moher. The network helps show where Eric D. Moher may publish in the future.

Co-authorship network of co-authors of Eric D. Moher

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Moher. A scholar is included among the top collaborators of Eric D. Moher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Moher. Eric D. Moher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Changi, Shujauddin M., Tohru Yokozawa, Tetsuya Yamamoto, et al.. (2017). Mechanistic investigation of a Ru-catalyzed direct asymmetric reductive amination reaction for a batch or continuous process scale-up: an industrial perspective. Reaction Chemistry & Engineering. 2(5). 720–739. 9 indexed citations
2.
Moher, David, et al.. (2008). Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. Canadian Medical Association Journal. 178(10). 1293–1301. 57 indexed citations
3.
Varie, David L., Christopher M. Beck, David Hay, et al.. (2007). Design, Development, and Scale-Up of a Selective meso-Epoxide Desymmetrization Process. Organic Process Research & Development. 11(3). 546–559. 16 indexed citations
4.
Zhang, Fuyao, Eric D. Moher, & Tony Y. Zhang. (2007). TMG catalyzed cyclopropanation of cyclopentenone. Illustration by a simple synthesis of bicyclo[3.1.0]hexane-2-one derivatives. Tetrahedron Letters. 48(18). 3277–3279. 11 indexed citations
5.
Liang, Jian, Richard E. Moore, Eric D. Moher, et al.. (2005). Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors. Investigational New Drugs. 23(3). 213–224. 49 indexed citations
6.
Moher, Eric D., et al.. (2004). Development of an Efficient Synthesis for a Nipecotate-Containing Immunopotentiator. Organic Process Research & Development. 8(4). 593–596. 5 indexed citations
7.
Martinelli, Michael J., Rajappa Vaidyanathan, Joseph M. Pawlak, et al.. (2002). Catalytic Regioselective Sulfonylation of α-Chelatable Alcohols:  Scope and Mechanistic Insight. Journal of the American Chemical Society. 124(14). 3578–3585. 139 indexed citations
8.
Shih, Chuan, Rima Al‐awar, Michael J. Martinelli, et al.. (2002). ChemInform Abstract: Synthesis and Structure—Activity Relationship Studies of Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides. ChemInform. 33(25). 2 indexed citations
9.
Moher, Eric D., et al.. (2002). Synthesis of Cryptophycin 52 Using the Shi Epoxidation. Organic Letters. 4(10). 1813–1815. 23 indexed citations
10.
Liang, Jian, et al.. (2000). Synthesis of Cryptophycin 52 Using the Sharpless Asymmetric Dihydroxylation:  Diol to Epoxide Transformation Optimized for a Base-Sensitive Substrate. The Journal of Organic Chemistry. 65(10). 3143–3147. 34 indexed citations
11.
Varie, David L., Chuan Shih, David Hay, et al.. (1999). Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region). Bioorganic & Medicinal Chemistry Letters. 9(3). 369–374. 31 indexed citations
12.
Martinelli, Michael J., Naresh K. Nayyar, Eric D. Moher, et al.. (1999). Dibutyltin Oxide Catalyzed Selective Sulfonylation of α-Chelatable Primary Alcohols. Organic Letters. 1(3). 447–450. 172 indexed citations
13.
Liang, Jian, Vien V. Khau, Michael J. Martinelli, et al.. (1999). Synthesis of Unit A of Cryptophycin via a [2,3]-Wittig Rearrangement. The Journal of Organic Chemistry. 64(5). 1459–1463. 26 indexed citations
14.
Moher, Eric D., Michael Reilly, Paul A. Grieco, Thomas H. Corbett, & Frederick A. Valeriote. (1998). Synthetic Studies on Quassinoids:  Transformation of (−)-Glaucarubolone into (−)-Peninsularinone. In Vivo Antitumor Evaluation of (−)-Glaucarubolone, (−)-Chaparrinone, and (−)-Peninsularinone. The Journal of Organic Chemistry. 63(10). 3508–3510. 8 indexed citations
15.
Grieco, Paul A., et al.. (1994). A quassinoid (peninsularinone) and a steroid from Castela peninsularis. Phytochemistry. 37(5). 1451–1454. 11 indexed citations
17.
Grieco, Paul A., Jon L. Collins, Eric D. Moher, Thomas J. Fleck, & Raymond S. Gross. (1993). Synthetic studies on quassinoids: total synthesis of (-)-chaparrinone, (-)-glaucarubolone, and (+)-glaucarubinone. Journal of the American Chemical Society. 115(14). 6078–6093. 71 indexed citations
18.
Moher, Eric D., Jon L. Collins, & Paul A. Grieco. (1992). Synthetic studies on quassinoids: total synthesis of simalikalactone D and assignment of the absolute configuration of the .alpha.-methylbutyrate ester side chain.. Journal of the American Chemical Society. 114(7). 2764–2765. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026